Dominique Bonneau
Professor of Medical Genetics
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Variants in RNU4-2 , encoding the small nuclear RNA (snRNA) U4, were recently identified as a major cause of neurodevelopmental disorders (ReNU syndrome). Here, we investigated de novo variants in 50 snRNAs in a French cohort of 23,649 individuals with rare disorders and collected data of additional patients through an international collaboration. Altogether, we identified 133 probands with pathogenic or likely pathogenic variants in RNU4-2 and 15 individuals with de novo and/or recurrent variants in constrained regions of RNU5B-1 , one of five genes encoding U5. These variants cluster in evolutionarily conserved regions of U4 and U5 essential for splicing. RNU4-2 variants affecting stem III are associated with milder phenotypes than those in the T-loop (quasi-pseudoknot). Phaseable variants associated with severe phenotypes occurred on the maternal allele. Individuals with RNU4-2 variants show specific defects in alternative 5’ splice site usage, correlating with variant location and clinical severity. Additionally, we report an episignature associated with severe ReNU syndrome. This study further highlights the importance of de novo variants in snRNAs and establishes RNU5B-1 as a new neurodevelopmental disorder gene.
Year:
2024
Neurodevelopmental proteasomopathies represent a distinctive category of neurodevelopmental disorders (NDD) characterized by genetic variations within the 26S proteasome, a protein complex governing eukaryotic cellular protein homeostasis. In our comprehensive study, we identified 23 unique variants in PSMC5 , which encodes the AAA-ATPase proteasome subunit PSMC5/Rpt6, causing syndromic NDD in 38 unrelated individuals. Overexpression of PSMC5 variants altered human hippocampal neuron morphology, while PSMC5 knockdown led to impaired reversal learning in flies and loss of excitatory synapses in rat hippocampal neurons. PSMC5 loss-of-function resulted in abnormal protein aggregation, profoundly impacting innate immune signaling, mitophagy rates, and lipid metabolism in affected individuals. Importantly, targeting key components of the integrated stress response, such as PKR and GCN2 kinases, ameliorated immune dysregulations in cells from affected individuals. These findings significantly advance our understanding of the molecular mechanisms underlying neurodevelopmental proteasomopathies, provide links to research in neurodegenerative diseases, and open up potential therapeutic avenues.
Year:
2024
Collaborators (39)
Caroline Schluth-Bolard
University of Lyon
Ype Elgersma
Full professor
Erasmus MC
Tamar Harel
-
Geeske van Woerden
Associate professor
Erasmus University Rotterdam
Julien Van-Gils
Aix-Marseille University
Rebecca Ganetzky
Associate Professor
Children's Hospital of Philadelphia
EFTERPI PAVLIDOU
Assistant Professor of Pediatrics
University of Ioannina
Peter Krawitz
University of Bonn
Julie Steffann
-
Arnaud Droit
Professor
Université Laval Faculté de médecine
Elsa Leitão
Universitätsklinikum Essen Institut für Humangenetik
Tzung-Chien Hsieh
University Hospital Bonn
Evan Eichler
Howard Hughes Medical Institute
Florence Petit
Université de Lille
Pierre Blanc
Head of the laboratory
Assistance Publique - Hôpitaux de Paris
Marie-Pierre Bousquet
Institute of Pharmacology and Structural Biology
Mathilde Renaud
Faculty member / Enseignant-chercheur / Enseignante-chercheuse
Université de Lorraine
Peter Werner Hildebrand
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Stéphane Bézieau
Université de Nantes
Andrew Dauber
The George Washington University School of Medicine and Health SCiences
Frederic Laumonnier
Team Leader, Research Director
INSERM
Dmitriy Niyazov
Associate Professor
Duke University
Renske Oegema
UMC Utrecht
Rami Abou Jamra
University Hospital Leipzig
Gael Nicolas
PUPH
University of Rouen
Jens Meiler
Vanderbilt University
Kimberly McDonald
Assistant Professor
University of Mississippi Medical Center
Elke Hammer
University Medicine Greifswald
Elke Krueger
Director
University Medicine Greifswald
Annick Toutain
-
Tychele Turner
Assistant Professor
Washington University School of Medicine
Benoit Arveiler
Prof - Group leader
Bordeaux University Hospital
Frédéric Ebstein
Group Leader
Université de Nantes
Andreas Grabrucker
Lecturer (Assist. Prof)
University of Limerick
Gregory Costain
Hospital for Sick Children
Antonio Vitobello
Full professor
Université de Bourgogne
Anita Rauch
University of Zurich
Julien Marcoux
CNRS Research Director
Institute of Pharmacology and Structural Biology
Miroslava Hancarova
Charles University
Make your next move.
Prepare your application
Review drafts before you send them.